Table 2 Comparison of patients’ clinical characteristics in the surgical and nonsurgical groups
Characteristic | Surgical group (n = 6) | Nonsurgical group (n = 5) | P value |
|---|---|---|---|
Age (years) | 45.3 ± 7.7 | 59.2 ± 3.9 | 0.247a |
Gender | 0.545b | ||
Male | 1 (16.7%) | 2 (40.0%) | |
Female | 5 (83.3%) | 3 (60.0%) | |
Time from symptoms and signs to treatment (days) | 3.5 ± 1.1 | 10.8 ± 5.5 | 0.329a |
Performance status (ECOG) | 0.455b | ||
< 2 | 2 (33.3%) | 0 (0.0%) | |
≥ 2 | 4 (66.7%) | 5 (100.0%) | |
Lactate dehydrogenase (IU/l) | 300.8 ± 38.4 | 433.2 ± 149.6 | 0.792a |
Extra-nodal involvement >1 site | 0.242b | ||
Yes | 2 (33.3%) | 4 (80.0%) | |
No | 4 (66.7%) | 1 (20.0%) | |
Stage | 0.545b | ||
1 | 3 (50.0%) | 1 (20.0%) | |
4 | 3 (50.0%) | 4 (80.0%) | |
International Prognostic Index score | 0.545b | ||
Low/low-intermediate | 3 (50.0%) | 1 (20.0%) | |
High/high-intermediate | 3 (50.0%) | 4 (80.0%) | |
Neurological deficit recovery | 0.015b | ||
Complete | 6 (100.0%) | 1 (20.0%) | |
Partial | 0 (0.0%) | 4 (80.0%) | |
Overall survival (months) | 48.6 ± 13.7 | 17.8 ± 3.4 | 0.177a |